This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: PKN Orlen shows even 'quasi-monopolies' can win EU approval with the right remedies

By Andrew Boyce ( July 17, 2020, 12:06 GMT | Comment) -- This week’s EU clearance of the PKN Orlen-Lotos merger in Poland is proof that well-aimed concessions can rescue a problematic deal, even very late in the day. The mixture of divestments and behavioral commitments managed to convince officials that competition would be maintained, even after the normal deadline for submitting remedies — offering lessons for lawyers working on other difficult merger cases.PKN Orlen’s creation of a "quasi-monopoly" through its merger with rival Polish oil refiner Lotos set alarm bells ringing in Brussels 11 months ago. Yet this week the deal was cleared....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login